The largest database of trusted experimental protocols

5 protocols using pioglitazone

1

PPAR Agonists and Antagonists Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dihydrotestosterone was purchased from Steraloids. PPAR agonists and antagonists were purchased from: GW1929 (Sigma), Pioglitazone (Santa Cruz), GW9662 (Sigma), T0070907 (Cayman Chemical).
+ Open protocol
+ Expand
2

Cell Culture and Reagent Acquisition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lung, renal cancer cell lines, and HEK293 cells were cultured in RPMI 1640 or DMEM medium supplemented with 5% or 10% fetal bovine serum (FBS), 50 U/mL penicillin, and 50 U/mL streptomycin at 37 °C with 5% CO2. Purchased are various chemicals including pioglitazone (Cat# sc-204848) from Santa Cruz, SU6656 (Cat# sc-203286A) from Santa Cruz or SU6656 (Cat# S7774) from Selleckchem, PP2 (Cat# 1767-1) from BioVision, HTS01037 (Cat# 10699-10) from Cayman Chemical and Stattic (Cat# S7947), Thiazolyl Blue Tetrazolium Blue (Cat# M2128) or Oil-red O (Cat# O1391) from Sigma-Aldrich. Included are cell lines for relevant experiments in this study (Table S1).
+ Open protocol
+ Expand
3

Inducible PPARγ Expression in Lung Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lung cancer cells were cultured in RPMI 1640 (H2073, H3255, H2347, Calu6, and H1993) or DMEM media (H1299 and A549) supplemented with 5% FBS, 50 U/mL penicillin, and 50 U/mL streptomycin, at 37°C, 5% CO2 atmosphere. Cells were periodically tested for mycoplasma contamination. HBEC stable cell lines with inducible PPARγ expression were generated as previously reported [15 (link)]. Particularly, HBEC cells containing wild-type PPARγ or sumoylation mutant PPARγ (K107, 395R), HBEC-PPARγWT and HBEC-PPARγSUMO, are two tumorigenic clones in which biotin ligase recognition peptide (BLRP)-tagged PPARγWT or PPARγSUMO are tightly regulated upon tetracycline treatment. HBEC cells were cultured in RPMI 1640 supplemented with 10% FBS, 50 U/mL penicillin and 50 U/mL streptomycin. PPARγ agonists (pioglitazone and troglitazone) were purchased from Santa Cruz, tetracycline was from Sigma.
+ Open protocol
+ Expand
4

Cell Culture Conditions for Cancer Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
GSCs, 448T, X01, X02, and 528 for PN and 0502, 83, and 1123 for MES, were cultured in DMEM/F-12 supplemented with B27 (Invitrogen, Carlsbad, CA), EGF (10 ng/ml, R&D Systems, Minneapolis, MN), bFGF (5 ng/ml, R&D Systems), 50 U/mL penicillin, and 50 U/mL streptomycin at 37 °C with 5% CO2. The cells were kindly provided by Jong Bae Park (National Cancer Center, South Korea) (448T, X01, X02, 528, 83, and 1123) and Myung-Jin Park (KIRAM, South Korea) (0502). Pioglitazone was purchased from Santa Cruz or Sigma-Aldrich. Troglitazone, SU6656, dasatinib, and gefitinib were obtained from Santa Cruz (Dallas, TX). 15-Deoxy-∆-11,13-prostaglandin J2 (15d-PGJ2), T0070907, azacitidine and bafilomycin A1 were from Sigma-Aldrich (St. Louis, MO). U0126 and helenalin were from Merck (Darmstadt, Germany) and ChemFaces (Hubei, China), respectively. ActiveMax® Recombinant human TNF-alpha was obtained from Acrobiosystems (Newark, DE).
+ Open protocol
+ Expand
5

Steroid and Vitamin K Antagonist Procurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dihydrotestosterone was purchased from Steraloids. Vitamin K antagonists were purchased from: warfarin sodium (TCI Chemicals), scopoletin (Sigma), brodifacoum (Sigma). Bicalutamide was purchased from Sigma. PPAR agonists and antagonists were purchased from: GW1929 (Sigma), Pioglitazone (Santa Cruz), GW9662 (Sigma).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!